Follow
Rathan Subramaniam
Rathan Subramaniam
Otago Medical School, University of Otago, New Zealand
Verified email at otago.ac.nz
Title
Cited by
Cited by
Year
Major histocompatibility complex class I–restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
C Kurts, JFAP Miller, RM Subramaniam, FR Carbone, WR Heath
The Journal of experimental medicine 188 (2), 409-414, 1998
4061998
Brain PET in the diagnosis of Alzheimer’s disease
C Marcus, E Mena, RM Subramaniam
Clinical nuclear medicine 39 (10), e413, 2014
2592014
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging
EH Dibble, ACL Alvarez, MT Truong, G Mercier, EF Cook, ...
Journal of Nuclear Medicine 53 (5), 709-715, 2012
2322012
Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis
RM Subramaniam, C Suarez-Cuervo, RF Wilson, S Turban, A Zhang, ...
Annals of internal medicine 164 (6), 406-416, 2016
1832016
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
CH Chung, VB Guthrie, DL Masica, C Tokheim, H Kang, J Richmon, ...
Annals of oncology 26 (6), 1216-1223, 2015
1582015
Thyroid-differentiated and anaplastic carcinoma
M Tuttle, LF Morris, B Haugen, J Shah, JA Sosa, E Rohren, ...
AJCC cancer staging manual 8, 873-90, 2017
1562017
Brain FDG PET and the diagnosis of dementia
VKN Shivamurthy, AK Tahari, C Marcus, RM Subramaniam
American Journal of Roentgenology 204 (1), W76-W85, 2015
1562015
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland
D Karantanis, TV Bogsrud, GA Wiseman, BP Mullan, RM Subramaniam, ...
Journal of Nuclear Medicine 48 (6), 896-901, 2007
1552007
Head and neck PET/CT: therapy response interpretation criteria (Hopkins criteria)—interreader reliability, accuracy, and survival outcomes
C Marcus, A Ciarallo, AK Tahari, E Mena, W Koch, RL Wahl, AP Kiess, ...
Journal of Nuclear Medicine 55 (9), 1411-1416, 2014
1492014
Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis
J Eng, RF Wilson, RM Subramaniam, A Zhang, C Suarez-Cuervo, ...
Annals of internal medicine 164 (6), 417-424, 2016
1152016
Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)
SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, P Xia, ...
Journal of Clinical Oncology 39 (9), 956, 2021
1142021
Fluorodeoxyglucose–positron-emission tomography imaging of head and neck squamous cell cancer
RM Subramaniam, M Truong, P Peller, O Sakai, G Mercier
American Journal of Neuroradiology 31 (4), 598-604, 2010
1142010
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma
V Paidpally, A Chirindel, S Lam, N Agrawal, H Quon, RM Subramaniam
Imaging in medicine 4 (6), 633, 2012
1102012
Value of PET/CT in the management of primary hepatobiliary tumors, part 2
A Sacks, PJ Peller, DS Surasi, L Chatburn, G Mercier, RM Subramaniam
American Journal of Roentgenology 197 (2), W260-W265, 2011
1062011
Clinical practice in PET/CT for the management of head and neck squamous cell cancer
R Goel, W Moore, B Sumer, S Khan, D Sher, RM Subramaniam
American Journal of Roentgenology 209 (2), 289-303, 2017
1052017
PET/CT of cancer patients: part 1, pancreatic neoplasms
EH Dibble, D Karantanis, G Mercier, PJ Peller, LA Kachnic, ...
American journal of roentgenology 199 (5), 952-967, 2012
972012
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT
Y Sanli, I Garg, A Kandathil, T Kendi, MJB Zanetti, S Kuyumcu, ...
American Journal of Roentgenology 211 (2), 267-277, 2018
942018
The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer
S Sheikhbahaei, E Mena, A Yanamadala, S Reddy, LB Solnes, ...
American Journal of Roentgenology 208 (2), 420-433, 2017
942017
Repeatability of 18F-FDG PET/CT in advanced non–small cell lung cancer: prospective assessment in 2 multicenter trials
WA Weber, CA Gatsonis, PD Mozley, LG Hanna, AF Shields, DR Aberle, ...
Journal of Nuclear Medicine 56 (8), 1137-1143, 2015
932015
Methods and challenges in quantitative imaging biomarker development
RG Abramson, KR Burton, JY John-Paul, EM Scalzetti, TE Yankeelov, ...
Academic radiology 22 (1), 25-32, 2015
912015
The system can't perform the operation now. Try again later.
Articles 1–20